GlaxoSmithKline Pakistan Revenue

In the year 2024, GlaxoSmithKline Pakistan had annual revenue of 61.19B PKR with 23.21% growth. GlaxoSmithKline Pakistan had revenue of 17.59B in the quarter ending December 31, 2024, with 39.22% growth.

Revenue

61.19B

Revenue Growth

+23.21%

P/S Ratio

2.31

Revenue / Employee

35.99M

Employees

1,700

Market Cap

141.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	61.19B	11.53B	23.21%
Dec 31, 2023	49.66B	7.82B	18.69%
Dec 31, 2022	41.84B	5.18B	14.13%
Dec 31, 2021	36.66B	1.57B	4.48%
Dec 31, 2020	35.09B	-1.49B	-4.08%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Abbott Laboratories (Pakistan)	68.18B
AGP Limited	25.03B
Highnoon Laboratories	24.63B
The Searle Company	28.80B
Shifa International Hospitals	25.45B
Citi Pharma	13.19B
Ferozsons Laboratories	16.82B
Otsuka Pakistan	3.37B

Revenue Rankings